Home » Genome Institute of Singapore, Undisclosed Pharma to Use Illumina's BeadChip

Genome Institute of Singapore, Undisclosed Pharma to Use Illumina's BeadChip

Nov 16, 2006
NEW YORK (GenomeWeb News) — The Genome Institute of Singapore will use Illumina's BeadChip technology to analyze 3,000 samples, Illumina said today.
 
The Institute will work with an undisclosed pharmaceutical company as they use Illumina’s HumanRef-8 Expression. No other information was provided.
 
Illumina said the technology enables researchers to perform genome-wide expression profiles on eight samples on a single microarray.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

What's Popular?

In Microarrays & Multiplexing

  1. Genentech Adapts Microfluidics Sequencing Method for Liquid Biopsy Applications

    Premium

  2. Researchers Identify SNP Set, Develop QR Code to Distinguish Genome Samples

  3. RNA-Editing Protein ADAR Promotes Progression of Lung Cancer, New Study Finds

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.